OptimUM-02 trial - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

RailTel (NSE: RAILTEL) wins Rs 164.78cr WCL deal as shares climb

Alkane Resources (ASX: ALK) posts A$228.7m profit and launches buyback

ZKH Group (NYSE: ZKH) posts first operating profit as GMV jumps 19%

Thunder Mountain Gold (TSXV: THM) closes C$8.1m South Mountain raise

Read More

Pharma Industry News

How the OptimUM-02 trial timeline may influence investor and clinical sentiment in ocular oncology

IDEAYA Biosciences nears darovasertib data. Find out how this Phase 3 readout could reshape metastatic uveal melanoma treatment today.

bySoujanya Ravi

March 25, 2026

web analytics